Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:57:33.153Z.
Calculation as of: 2026-10-06T16:57:33.153Z.
Quote observation: 2026-10-06T16:54:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 85842aa9b6cc8ebfa961f669867d571d507c26eab2d350d24b64fb3509ac0979
EARNINGS YIELD
N/A
Market Cap
$19.53M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Modular Medical, Inc. (MODD) | $21.76M | N/A | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.11M | N/A | N/A | N/A | N/A |
| LeonaBio, Inc. (LONA)vs › | $22.36M | N/A | N/A | N/A | N/A |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.99M | N/A | N/A | N/A | N/A |
| Rein Therapeutics Inc. (RNTX)vs › | $22.98M | N/A | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $20.01M | N/A | N/A | N/A | N/A |
| P3 Health Partners Inc. (PIII)vs › | $19.67M | N/A | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.53M | N/A | N/A | N/A | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $24.09M | N/A | 0.04% | 0.04% | 0.04% |
| NextCure, Inc. (NXTC)vs › | $18.95M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute